Clinical manifestations of hyperthyroidism after treatment with selective beta 1 adrenoceptor blocking agents.
Shikara
Mazin M
MM
Flushing Hospital Medical Center, Flushing, New York, USA. mzshikara@hotmail.com
Polena
Sotir
S
Solinas
Alessandro
A
Sanghvi
Kintur
K
Gintautas
Jonas
J
D000293:Adolescent; D058671:Adrenergic beta-1 Receptor Antagonists; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D001262:Atenolol / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008790:Metoprolol / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D011433:Propranolol / Q000009:adverse effects / Q000627:therapeutic use; D011863:Radioimmunoassay; D013963:Thyroid Hormones / Q000097:blood; D015430:Weight Gain / Q000187:drug effects
D058671:Adrenergic beta-1 Receptor Antagonists; D000319:Adrenergic beta-Antagonists; D013963:Thyroid Hormones; D001262:Atenolol; D011433:Propranolol; D008790:Metoprolol